A Phase 1, First-in-human Study of VX-433

NCT07584434 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

118

Enrollment

INDUSTRY

Sponsor class

Conditions

Narcolepsy Type 1 (NT1)

Interventions

DRUG: VX-433
DRUG: Placebo
DRUG: Midazolam
DRUG: Bupropion

Sponsor

Vertex Pharmaceuticals Incorporated